# Comparative Bioavailability Study of Two Test Products of Fixed Dose Combination Capsule of ASA (Acetylsalicylic Acid) and Pantoprazole (Each Capsule Contains ASA 100 mg and Pantoprazole 20 mg) Under Fasting Conditions

> **NCT01847404** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 24 (actual)

## Conditions studied

- Ulcers, Duodenal and Gastric

## Interventions

- **DRUG:** Test 1= ASA 100 mg and pantoprazole 20 mg capsule formulation one
- **DRUG:** Test 2= ASA 100 mg and pantoprazole 20 mg capsule formulation two
- **DRUG:** ASA 100 mg tablet
- **DRUG:** Pantoprazole 20 mg gastro-resistant tablet

## Key facts

- **NCT ID:** NCT01847404
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05-14
- **Primary completion:** 2013-06-28
- **Final completion:** 2013-06-28
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2017-07-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01847404

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01847404, "Comparative Bioavailability Study of Two Test Products of Fixed Dose Combination Capsule of ASA (Acetylsalicylic Acid) and Pantoprazole (Each Capsule Contains ASA 100 mg and Pantoprazole 20 mg) Under Fasting Conditions". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01847404. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*